Clinical Trial Update: ALA on Glycemic Control in T2DM Participants

View source ↗

Summary

This document provides an update on a clinical trial evaluating the effects of alpha-lipoic acid (ALA) on glycemic control in participants with Type 2 Diabetes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Unity Health Toronto | Conditions: Type 2 Diabetes Mellitus | Status: UNKNOWN